Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs (BioSTaR)
Observational Registry (BioSTaR) Including Demographic and Clinical Data of Patients Diagnosed With Rheumatoid Arthritis and Spondyloarthritis Using a Biological and Targeted Synthetic Disease Modifying Drug
Sponsor: Turkish League Against Rheumatism
Listed as NCT04139954, this observational or N/A phase trial focuses on Rheumatoid Arthritis and Spondyloarthritis and remains ongoing. Sponsored by Turkish League Against Rheumatism, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Nov 2019 — Jan 2021 [monthly]
Recruiting
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Turkish League Against Rheumatism
For direct contact, visit the study record on ClinicalTrials.gov .